Cargando…
Optimizing COPD treatment in patients with lung- or head and neck cancer does not improve quality of life – a randomized, pilot, clinical trial
Background: Chronic obstructive pulmonary disease (COPD) is a common comorbidity in patients with lung and head- and neck cancer. Patients with lung cancer who also suffer from COPD have a worse prognosis than patients with lung cancer and no COPD. It has previously been shown that diagnosis and tre...
Autores principales: | Gottlieb, Magnus, Mellemgaard, Anders, Marsaa, Kristoffer, Godtfredsen, Nina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067155/ https://www.ncbi.nlm.nih.gov/pubmed/32194927 http://dx.doi.org/10.1080/20018525.2020.1731277 |
Ejemplares similares
-
Feasibility of a telecare solution for patients admitted with COPD exacerbation: screening data from a pulmonary ward in a university hospital
por: Gottlieb, Magnus, et al.
Publicado: (2014) -
Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
por: Godtfredsen, Nina S., et al.
Publicado: (2018) -
High suPAR and Low Blood Eosinophil Count are Risk Factors for Hospital Readmission and Mortality in Patients with COPD
por: Håkansson, Kjell E J, et al.
Publicado: (2020) -
Oral prednisolone for 4 days does not increase exercise tolerance in men with COPD
por: Karlsson, SL, et al.
Publicado: (2017) -
COPD, stage and treatment in a large outpatient clinic
por: Holm, Claire Præst, et al.
Publicado: (2017)